The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
出版年份 2019 全文链接
标题
The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HEART FAILURE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-07-16
DOI
10.1002/ejhf.1548
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)
- (2019) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR)
- (2018) Suzanne V. Arnold et al. AMERICAN HEART JOURNAL
- Health Status Variation Across Practices in Outpatients With Heart Failure
- (2018) Yevgeniy Khariton et al.
- SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
- (2018) Subodh Verma et al. DIABETOLOGIA
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2018) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Medical Therapy for Heart Failure With Reduced Ejection Fraction
- (2018) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Health Status Variation Across Practices in Outpatients With Heart Failure
- (2018) Yevgeniy Khariton et al. Circulation-Cardiovascular Quality and Outcomes
- Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial
- (2018) Adam D. DeVore et al. Journal of the American Heart Association
- Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison
- (2018) Suzanne V. Arnold et al. DIABETES OBESITY & METABOLISM
- Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes
- (2018) Thomas A. Zelniker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
- (2018) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study
- (2018) Tiew-Hwa K Teng et al. Lancet Global Health
- Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
- (2018) Silvio E. Inzucchi et al. CIRCULATION
- Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN‐HF registry
- (2018) Chanchal Chandramouli et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial
- (2017) Søren L. Kristensen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
- (2017) Ovidiu Chioncel et al. EUROPEAN JOURNAL OF HEART FAILURE
- The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors
- (2017) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial
- (2017) Marco Dauriz et al. Journal of the American Heart Association
- Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
- (2017) Jelena P Seferovic et al. Lancet Diabetes & Endocrinology
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure
- (2017) Milton Packer et al. JAMA Cardiology
- Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE
- (2016) Søren L. Kristensen et al. Circulation-Heart Failure
- Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register
- (2016) Katarina Eeg-Olofsson et al. Diabetes & Vascular Disease Research
- Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry
- (2016) Carolyn S.P. Lam et al. EUROPEAN HEART JOURNAL
- Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions
- (2016) Nihar R. Desai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
- (2016) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
- (2015) Michel Komajda et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
- (2015) Oliver J Ziff et al. BMJ-British Medical Journal
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
- (2015) Oliver J Ziff et al. BMJ-British Medical Journal
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
- (2013) Aldo P. Maggioni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial
- (2012) Satyam Sarma et al. EUROPEAN JOURNAL OF HEART FAILURE
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival
- (2010) Domenico Scrutinio et al. EUROPEAN JOURNAL OF HEART FAILURE
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started